JAK2 inhibitors and their impact in myeloproliferative neoplasms.

Geyer, Holly L

JAK2 inhibitors and their impact in myeloproliferative neoplasms. [electronic resource] - Hematology (Amsterdam, Netherlands) Apr 2012 - S129-32 p. digital

Publication Type: Journal Article

1607-8454

10.1179/102453312X13336169156375 doi


Animals
Benzamides--pharmacology
Bridged-Ring Compounds--pharmacology
Carbazoles--pharmacology
Furans
Humans
Janus Kinase 2--antagonists & inhibitors
Myeloproliferative Disorders--drug therapy
Nitriles
Protein Kinase Inhibitors--pharmacology
Pyrazoles--pharmacology
Pyrimidines--pharmacology
Pyrrolidines--pharmacology
Sulfonamides--pharmacology